Davis Polk Advises Aetna on Its Acquisition by CVS Health

Davis Polk is advising Aetna on its approximately $77 billion acquisition by CVS Health. The transaction, which is expected to close in the second half of 2018, is subject to approval by Aetna and CVS Health shareholders, regulatory approvals and other customary closing conditions.

Aetna is one of the nation’s leading diversified health care benefits companies, serving an estimated 44.6 million, as of September 30, 2017, people with information and resources to help them make better informed decisions about their health care. CVS Health is a pharmacy innovation company helping people on their path to better health.

The Davis Polk corporate team includes partners Oliver Smith, John A. Bick and Harold Birnbaum and associate Darren M. Schweiger. Partners Howard Shelanski and Jesse Solomon are providing antitrust and competition advice. Partner Edmond T. FitzGerald is providing executive compensation advice. Partner Shane Tintle is providing capital markets advice. Partner William A. Curran is providing tax advice. Members of the Davis Polk team are based in the New York and Washington DC offices.

Scroll to Top